NEW YORK (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on…
Super UserNovember 4, 2019
GAITHERSBURG, Md., Oct. 31, 2019 (GLOBE NEWSWIRE) — NexImmune, a clinical stage immunotherapy company developing novel T cell therapies, received…
Super UserNovember 4, 2019
The biotech company is developing a cell therapy that could help patients who have suffered a heart attack. It’s the…
Super UserNovember 4, 2019
To cap off the TEDCO Entrepreneur Expo, there was a special ribbon cutting ceremony to welcome the Association of University…
Super UserNovember 4, 2019
AstraZeneca and BioHealth Innovations, Inc is hosting the semi-annual Bio Networking event on November 6th from 3pm-5pm at the AstraZeneca…
Super UserNovember 4, 2019
Michael Lenardo, M.D., Chief, Molecular Development of the Immune System Section NIAID/DIR, joins Rich Bendis on BioTalk to discuss his…
Super UserOctober 31, 2019
Michael Lenardo, M.D., Chief, Molecular Development of the Immune System Section NIAID/DIR, joins Rich Bendis on BioTalk to discuss his…
Super UserOctober 31, 2019
The second annual Biohealth Capital Region Investment Conference attracted 108 companies and 47 participating investors—both conference records—and has already resulted…
Super UserOctober 31, 2019
On Thursday, November 7, join JLABS @ Washington, DC as representatives from Johnson & Johnson Innovation provide an overview of…
Super UserOctober 28, 2019